Evolus, Inc. (EOLS) vs Oculis Holding AG (OCS)
A side-by-side comparison of Evolus, Inc. and Oculis Holding AG across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EOLS
Evolus, Inc.
$7.45HealthcareDelayed quote: Oct 6, 2026, 1:00 PM EDT
OCS
Oculis Holding AG
$8.65HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT
Total return — EOLS vs OCS
growth of $100 · dividends reinvested · last 5yEOLS -16.5% (-3.6%/yr)OCS -11.8% (-2.5%/yr)OCS compounded faster over this window
EOLS OCS
EOLS vs OCS: by the numbers
- •OCS is the larger company ($494M vs $490M market cap).
- •Both run net losses; EOLS's is the smaller (-10.85% vs -32724.20% net margin).
Metrics side by side
Valuation
| Metric | EOLS | OCS |
|---|---|---|
| P/S ratio | 1.55 | 1620.77 |
| P/B ratio | N/A | 1.82 |
Profitability
| Metric | EOLS | OCS |
|---|---|---|
| Gross margin | 66.25% | 0.00% |
| Operating margin | -7.33% | 0.00% |
| Net margin | -10.85% | -32724.20% |
| ROE | N/A | -36.79% |
| ROIC | -15.54% | -39.63% |
Growth (annualized)
| Metric | EOLS | OCS |
|---|---|---|
| Revenue CAGR (5Y) | 32.82% | N/A |
| Total return CAGR (5Y) | 0.46% | -2.41% |
Frequently asked
- How have EOLS and OCS total returns compared?
- Over the past 5 years, EOLS delivered 0.46% and OCS delivered -2.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Evolus ROEOculis Holding AG ROEEvolus operating marginOculis Holding AG operating marginEvolus revenue growthOculis Holding AG revenue growthEvolus free cash flowOculis Holding AG free cash flow
Evolus & Oculis Holding AG appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.